Serum hepcidin levels and osteoporosis in patients with rheumatoid arthritis

2017 Fiscal Year Final Research Report

• Project/Area Number: 15K19571
• Research Category: Grant-in-Aid for Young Scientists (B)
• Allocation Type: Multi-year Fund
• Research Field: Collagenous pathology/Allergology
• Research Institution: Niigata University
• Principal Investigator: Sato Hiroe 新潟大学, 保健管理・環境安全本部, 講師 (80705963)
• Project Period (FY): 2015-04-01 – 2018-03-31
• Keywords: ヘプシジン / 関節リウマチ / 骨粗鬆症

Outline of Final Research Achievements

This study investigated the serum level of hepcidin in patients with rheumatoid arthritis (RA) and sought to identify association between osteoporosis and inflammation, and differences in hepcidin levels among patients treated with certain therapeutic drugs. Serum hepcidin levels were related to the anemia of inflammation but not to bone metabolic markers and bone mineral density in patients with RA. Serum hepcidin levels were different among certain therapeutic drugs.

Free Research Field

リウマチ膠原病